• Users Online: 45
  • Print this page
  • Email this page

  Download PDF

A real-world analysis of relapse rate and efficacy of a restricted monthly dose of omalizumab in recalcitrant chronic spontaneous urticaria in India

Download fre pdf Download for citation manager
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here

Support open access
Recommend this journal

Subscribe onlinePayments through
  Advanced Search 
  Apply as Reviewer